Dr. David M. Saravitz

David M. Saravitz, Ph.D. is a biotechnology and life sciences patent attorney who advises agtech, biologics, and diagnostics companies on protecting and commercializing innovation through strategic intellectual property (IP) planning. With more than 25 years of experience in intellectual property law and advanced scientific training, he helps clients build, manage, and leverage global patent portfolios that align with business growth, regulatory pathways, and commercialization goals.

Dr. Saravitz focuses his practice on life sciences and biotechnology patent law, including agricultural biotechnology, genome engineering technologies, biologics and biologic therapies, and molecular diagnostics . He has extensive experience in U.S. and foreign patent prosecution and has secured patent protection for clients across North America, South America, Europe, Asia, Australia, and Africa.

His practice includes patent drafting and prosecution, freedom-to-operate and non-infringement analyses, patentability and validity opinions, IP due diligence for mergers, acquisitions, and licensing transactions, and strategic patent portfolio development. Dr. Saravitz counsels clients on patent strategy to support product development, regulatory exclusivity, investment readiness, and market entry.

Dr. Saravitz represents early-stage startups, emerging growth companies, established life sciences companies, universities, and nonprofit research institutions. His technical experience spans a broad range of biotechnology and diagnostics technologies, including medical and molecular diagnostic tests, engineered DNA-binding proteins, genome editing systems, protein expression platforms, transgenic and non-transgenic crops, plant transformation methods, insecticidal proteins, plant growth regulators, probiotic and microbiome-based products, biofuels, and bioplastics. His prior experience as a research scientist enables him to provide practical, business-oriented IP advice grounded in real-world R&D and commercialization considerations.

Dr. Saravitz is admitted to practice before the United States Patent and Trademark Office (USPTO) and advises clients on both domestic and foreign patent matters.

He earned his J.D. from North Carolina Central University School of Law, where he served as chair of the Intellectual Property Law Society. His scientific credentials include a Ph.D. in Cell and Molecular Biology from Duke University, an M.S. from North Carolina State University, and a B.S., with distinction, from The Pennsylvania State University. While at Duke, he received a National Institutes of Health Cell and Molecular Biology Training Grant and a Plant Molecular Biology Fellowship from the North Carolina Biotechnology Center.

Dr. Saravitz is also a co-inventor of U.S. Patent No. 6,284,711, with corresponding patents in Argentina, Australia, Brazil, Canada, China, Eurasia, Europe, Mexico, New Zealand, South Korea, and South Africa.